Before reading more about CBD, make sure you consult your physician or other medical professional prior to taking CBD. The scientific studies listed below do not represent you or your specific conditions. Many of the studies below are preclinical and have not been re-studied in humans.
The statements on our website have not been evaluated by the Food and Drug Administrations. P•H•A•R•M CBD products are not intended to diagnose, treat, cure, or prevent any disease. The studies that are described on this page were not conducted by P•H•A•R•M CBD, LLC. They are provided for informational purposes only. We encourage all people interested in CBD to do their own research on the risks and benefits of CBD prior to taking it. P•H•A•R•M CBD, LLC is not liable for damages arising from the use of this information.
Preclinical and clinical investigations have studied a wide variety of health benefits of CBD, including:
According to the National Institute of Health, manipulating the endocannabinoid system by introducing external cannabinoids like CBD could be useful in regulating a variety of other medical ailments, including:
- Multiple Sclerosis (MS)
- Amyotrophic Lateral Sclerosis (ALS)
- Broken Bones
- Mad Cow Disease
- Bacterial Infections
- Rheumatoid Arthritis
- Substance Abuse/Withdrawal
- Heart Disease
- Irritable Bowel Syndrome (IBS)
Below is a list of additional studies that investigate the potential benefits of CBD:
Esposito, Giuseppe, et al. ” PloS one 6.12 (2011): e28668
O’Connell, Brooke K., David Gloss, and Orrin Devinsky. Ep. & Behavior 70 (2017): 341-348.
Leweke, F. M., et al. Translational psychiatry 2.3 (2012): e94.
Ramer, Robert, et al. The FASEB Journal 26.4 (2012): 1535-1548.
Massi, Paola, et al. Journal of pharmacology and Experimental Therapeutics 308.3 (2004): 838-845.
Shrivastava, Ashutosh, et al. Molecular Can. therapeutics (2011): molcanther-1100.
McAllister, Sean D., et al. Breast Can. research and treatment 129.1 (2011): 37-47.
Ramer, Robert, et al. Biochemical pharmacology 79.7 (2010): 955-966.
Vaccani, Angelo, et al. British journal of pharmacology 144.8 (2005): 1032-1036.